scroll to top
0

Mobile Menu

Header Layout

EBSCO Auth Banner

Let's find your institution. Click here.

Page title

Advanced Search Results For "Adams VW"

1 - 10 of 35 results for
 "Adams VW"
Results per page:

Geographical similarity and differences in the burden and genetic predisposition of NAFLD.

Publication Type:Academic Journal

Source(s):Hepatology (Baltimore, Md.) [Hepatology] 2022 Sep 05. Date of Electronic Publication: 2022 Sep 05.

Abstract:Nonalcoholic fatty liver disease (NAFLD) has become a major public health problem for more than 2 decades with a growing prevalence in parallel with the epidemic of obesity and type 2 diabetes. The disease burden of NAFLD differs across geographical re...

View details

Family and parent-child relationship correlates of pediatric cancer survivors' substance use.

Publication Type:Academic Journal

Source(s):Journal of cancer survivorship : research and practice [J Cancer Surviv] 2022 Apr; Vol. 16 (2), pp. 329-337. Date of Electronic Publication: 2021 Mar 17.

Abstract:Objective: The primary aims of this research were to examine substance use among adolescent and young adult survivors of pediatric cancer (AYA survivors) and AYA without a history of chronic or life threatening illness (AYA comparisons) and to explore ...

View details

Administrative Coding in Electronic Health Care Record-Based Research of NAFLD: An Expert Panel Consensus Statement.

Publication Type:Academic Journal

Source(s):Hepatology (Baltimore, Md.) [Hepatology] 2021 Jul; Vol. 74 (1), pp. 474-482. Date of Electronic Publication: 2021 Jun 22.

Abstract:Background and Aims: Electronic health record (EHR)-based research allows the capture of large amounts of data, which is necessary in NAFLD, where the risk of clinical liver outcomes is generally low. The lack of consensus on which International Classi...

View details

ABIDE: An Accurate Predictive Model of Liver Decompensation in Patients With Nonalcoholic Fatty Liver-Related Cirrhosis.

Publication Type:Academic Journal

Source(s):Hepatology (Baltimore, Md.) [Hepatology] 2021 Jun; Vol. 73 (6), pp. 2238-2250. Date of Electronic Publication: 2021 Apr 19.

Abstract:Background and Aims: Nonalcoholic fatty liver disease (NAFLD) is an increasingly important cause of liver cirrhosis and subsequent complications. We retrospectively developed and validated a model to predict hepatic decompensation in patients with NAFL...

View details

Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel: A Meta-analysis.

Publication Type:Academic Journal

Source(s):JAMA neurology [JAMA Neurol] 2021 Jan 01; Vol. 78 (1), pp. 102-113.

Abstract:Importance: Compared with non-Hispanic White individuals, African American individuals from the same community are approximately twice as likely to develop Alzheimer disease. Despite this disparity, the largest Alzheimer disease genome-wide association...

View details

Type 2 Diabetes and Metformin Use Associate With Outcomes of Patients With Nonalcoholic Steatohepatitis-Related, Child-Pugh A Cirrhosis.

Publication Type:Academic Journal

Source(s):Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2021 Jan; Vol. 19 (1), pp. 136-145.e6. Date of Electronic Publication: 2020 May 08.

Abstract:Background & Aims: Factors that affect outcomes of patients with nonalcoholic steatohepatitis (NASH)-related cirrhosis are unclear. We studied associations of type 2 diabetes, levels of hemoglobin A1c (HbA1c), and use of antidiabetic medications with s...

View details

Because Black Lives Did Not Matter.

Publication Type:Academic Journal

Source(s):The American journal of nursing [Am J Nurs] 2021 Jan 01; Vol. 121 (1), pp. 11.

Abstract:Yes, all lives do matter-but some have been valued a lot less highly for quite some time. (Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.)

View details

The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease.

Publication Type:Editorial & Opinion

Source(s):Hepatology international [Hepatol Int] 2020 Dec; Vol. 14 (6), pp. 889-919. Date of Electronic Publication: 2020 Oct 01.

Abstract:Metabolic associated fatty liver disease (MAFLD) is the principal worldwide cause of liver disease and affects nearly a quarter of the global population. The objective of this work was to present the clinical practice guidelines of the Asian Pacific As...

View details

Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical Trial.

Publication Type:Academic Journal

Source(s):Journal of clinical medicine [J Clin Med] 2020 Nov 16; Vol. 9 (11). Date of Electronic Publication: 2020 Nov 16.

Abstract:SRX246 is a vasopressin (AVP) 1a receptor antagonist that crosses the blood-brain barrier. It reduced impulsive aggression, fear, depression and anxiety in animal models, blocked the actions of intranasal AVP on aggression/fear circuits in an experimen...

View details

banner_970x250 (970x250)

sponsored